Correction: Total syntheses of Kavaratamide A and 5--Kavaratamide A.

Org Biomol Chem

State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy, Nankai University, Tianjin 300350, People's Republic of China.

Published: January 2025

Correction for 'Total syntheses of Kavaratamide A and 5--Kavaratamide A' by Tieshun Ren , , 2025, https://doi.org/10.1039/d4ob01409j.

Download full-text PDF

Source
http://dx.doi.org/10.1039/d4ob90164aDOI Listing

Publication Analysis

Top Keywords

syntheses kavaratamide
8
kavaratamide 5--kavaratamide
8
correction total
4
total syntheses
4
5--kavaratamide correction
4
correction 'total
4
'total syntheses
4
5--kavaratamide tieshun
4
tieshun ren
4
ren 2025
4

Similar Publications

Correction: Total syntheses of Kavaratamide A and 5--Kavaratamide A.

Org Biomol Chem

January 2025

State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy, Nankai University, Tianjin 300350, People's Republic of China.

Correction for 'Total syntheses of Kavaratamide A and 5--Kavaratamide A' by Tieshun Ren , , 2025, https://doi.org/10.1039/d4ob01409j.

View Article and Find Full Text PDF

Total syntheses of Kavaratamide A and 5--Kavaratamide A.

Org Biomol Chem

December 2024

State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy, Nankai University, Tianjin 300350, People's Republic of China.

The total synthesis of Kavaratamide A, a new Linear Lipodepsipeptide from the Marine Cyanobacterium was achieved by assembling the side chain in stage through condensation coupling, carbon-chain extension, Steglich esterification and Evans aldol reaction. In addition, total synthesis of Kavaratamide A's isomer, 5--kavaratamide A, is also successfully achieved. Cytotoxicity test suggested that Kavaratamide A and 5--Kavaratamide A have a moderate bioactivity against cancer cells.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!